Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16676162 | 1.00 | DGAT1 (0.41) | DGAT1MAPTLMNASLC6A4MAOA | |
| SCHEMBL10049917 | 0.77 | MEN1 (0.42) | LMNASLC6A4MAOA | |
| SCHEMBL2174245 | 0.77 | CHRNB2 (0.43) | MAPTLMNASLC6A4MAOAALDH1A1 | |
| SCHEMBL20482098 | 0.76 | SLC5A2 (0.34) | SLC6A4MAOA | |
| SCHEMBL1145839 | 0.76 | — | — | |
| SCHEMBL29978927 | 0.76 | — | — | |
| SCHEMBL17688642 | 0.75 | SLC6A4 (0.36) | SLC6A4MAOA | |
| SCHEMBL609195 | 0.75 | KDM4E (0.53) | SLC6A4MAOAPIK3CD | |
| SCHEMBL20448227 | 0.75 | SLC6A4 (0.36) | SLC6A4MAOA | |
| SCHEMBL29488699 | 0.75 | SLC6A4 (0.36) | SLC6A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514251-B2 | Fused heterocyclic compounds and their use as pest control agents | PI INDUSTRIES LTD. (IN) | 2026-01-06 | — | — | US | disclosed |
| US-20230089381-A1 | FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | PI INDUSTRIES LTD. (IN) | 2023-03-23 | — | — | US | disclosed |
| CN-112824402-B | Benzimidazole derivative, preparation method and application thereof | 浙江省化工研究院有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-109689630-B | Diaryl azole compound and pest control agent | 日本曹达株式会社 | 2022-06-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089381-A1 | FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | DDT, ACHE, CBR1 | DGAT1 4629/4885MAPT 4361/4885LMNA 1059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.